Abstract
Psoriasis is a chronic immune‐modulated condition affecting approximately 2‐3% of the general population. In addition to cutaneous lesions, psoriasis is associated with systemic and mental health co‐morbidities. Psoriasis is among the most extensively researched dermatologic conditions, with many novel treatment options in the drug development pipeline.
This article is protected by copyright. All rights reserved.
http://bit.ly/2MJbOov
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου